ReviewArteriosclerosis, thrombosis, and vascular biology2018

CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.

Alexandra C Chadwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.